DOI: https://doi.org/10.18370/2309-4117.2020.54.95-98

Prevention of genital prolapse recurrence in elderly women after surgery

Р. А. Сафонов, В. В. Лазуренко, О. Л. Черняк, О. А. Лященко, О. Б. Овчаренко

Abstract


Genital prolapse (GP) is one of the leading gynecological diseases and is diagnosed in 30–50% of women, especially the elder ones. Its related disorders lead to social, psychological and clinical disorders in the form of social isolation, depression, sexual dysfunction, etc.

Purpose of the study was to optimize the prevention of GP recurrence in elderly women after surgery.

Materials and methods. 56 women aged from 60 to 82 with GP of III–IV degree of severity were examined and divided into 2 groups depending on the treatment method and prevention. 26 women in the first group were prescribed vaginal suppositories Revitaxа for 30 days after surgical treatment to increase the GP recurrence prevention. 30 women in the second group underwent traditional surgical treatment of GP without additional local therapy. Surgical treatment of women with GP included transvaginal extirpation of uterus without appendages, anterior colporrhaphy, colpoperineoraphy with levatoroplasty, sacrospinal colpopexy in 39 (69.6%) patients and anterior colporrhaphy, colpoperineoraphy with levatoperoplasty in 17 patients. Operation was supplemented by laparoscopic intervention due to the need to ovary remove in 2 women.

Results. The proposed method of GP recurrence prevention in elderly women (unilateral sacrospinal fixation of the vaginal dome during surgical treatment of GP III–IV degrees which was followed by using vaginal suppositories Revitaxа for 30 days) allowed obtaining a 100% result in contrast to 90% in women with surgical treatment of GP without Revitaxа.

Conclusion. The unilateral sacrospinal fixation of the vaginal dome during surgical treatment of GP III–IV degrees and using vaginal suppositories Revitaxа for 30 days after surgery is recommended to prevent the recurrence of GP in elderly women

Keywords


genital prolapse; prevent recurrence; Revitaxа

References


Lologaeva, M.S., Arutin, D.G., Orazov, M.R. “Pelvic organ prolapse in the 21st century.” Obstetrics and gynecology: news, opinions, training 7.3 (2019): 76-82.

Buyanova, S.N., Shchukina, N.A., Zubova, E.S. “Genital prolapse.” Russian Bulletin of Obstetrician-Gynecologist 17.1 (2017): 37–45.

Aleixo, G.F., Fonseca, M.C.M., Bortolini, M.A.T., et al. “Pelvic floor symptoms 5 to 14 years after total versus subtotal hysterectomy for benign conditions: a systematic review and meta-analysis.” International Urogynecology Journal 30.2 (2019): 181–90.

Meriwether, K.V., Antosh, D.D., Olivera, C.K., Kim-Fine, S. “Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines.” Am J Obstet Gynecol 219.2 (2018): 129–46.

Horoviy, V.І., Mazorchuk, B.F. , Shaprinskyi, V.O. Practical urogynecology: course of lectures. Vinnytsia Regional Printing House (2015): 417–82.

Sun, Z., Zhu, L., Xu, T., et al. “Effects of preoperative vaginal estrogen therapy for the incidence of mesh complication after pelvic organ prolapse surgery in postmenopausal women: is it helpful or a myth? A 1-year randomized controlled trial.” Menopause 23.7 (2016): 740–8.

Cadish, L.A., West, E.H., Sisto, J., et al. “Preoperative vaginal estrogen and midurethral sling exposure: a retrospective cohort study.” Int Urogynecol J 27.3 (2016): 413–7.

Pamfamirov, Y.K., Romanenko, N.M., Puchkina, G.A., Samoylenko, A.V.

“On the issue of surgical treatment of genital prolapse.” Bulletin of Science and Education 2.26 (2017): 92–5.

Al-Zahrani, A.A., Gajewski, J. “Urodynamic findings in women with refractory overactive bladder symptoms.” Int J Urol 23.1 (2016): 75–9.

Caliskan, A., Ozeren, M., Goeschen, K. “Modified posterior intravaginal slingplasty: does the additional bilateral tape attachment to the sacrospinous ligament improve the results?” Cent European J Urol 71.3 (2018): 326–33.

Basu, M., Wise, B., Duckett, J. “Urgency resolution following prolapse surgery: is voiding important?” Int Urogynecol J 24.8 (2013): 1309–13.

Goeschen, K. “Role of uterosacral ligaments in the causation and cure of chronic pelvic pain syndrome.” Pelviperineology 34 (2015): 2–20.

Reznichenko, N.A., Belyavtseva, E.F. “Diagnostics and treatment of cervical pathology associated with sexually transmitted diseases.” Women's Health 10.86 (2013): 39–43.

Patent No. 142834 Ukraine, А61В 17/00. Treatment and prevention of recurrence of grade 3–4 genital prolapse in women with kidney disease / Lazurenko, V.V., Safonov, R.A., Lyashchenko, O.A., Ovcharenko, O.B., Kalinovska, O.I.; No. u2020 00986; appl. 02.17.2020; publ. 06.25.2020, Bull. No. 12.


GOST Style Citations


1.      Лологаева, М.С. Пролапс тазовых органов в XXI в. / М.С. Лологаева, Д.Г. Арютин, М.Р. Оразов // Акушерство и гинекология: новости, мнения, обучение. – 2019. – №7 (3). – С. 76–82.

2.      Буянова, С.Н. Пролапс гениталий / С.Н. Буянова, Н.А. Щукина, Е.С. Зубова // Российский вестник акушера-гинеколога. – 2017. – № 17 (1). – С. 37–45.

3.      Aleixo, G.F., Fonseca, M.C.M., Bortolini, M.A.T., et al. “Pelvic floor symptoms 5 to 14 years after total versus subtotal hysterectomy for benign conditions: a systematic review and meta-analysis.” International Urogynecology Journal 30.2 (2019): 181–90.

4.      Meriwether, K.V., Antosh, D.D., Olivera, C.K., Kim-Fine, S. “Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines.” Am J Obstet Gynecol 219.2 (2018): 129–46.

5.      Горовий, В.І. Практична урогінекологія: курс лекцій / В.І. Горовий, Б.Ф. Мазорчук, В.О. Шапринський. – Вінницька обласна друкарня, 2015. – С. 417–482.

6. Sun, Z., Zhu, L., Xu, T., et al. “Effects of preoperative vaginal estrogen therapy for the incidence of mesh complication after pelvic organ prolapse surgery in postmenopausal women: is it helpful or a myth? A 1-year randomized controlled trial.” Menopause 23.7 (2016): 740–8.

7.      Cadish, L.A., West, E.H., Sisto, J., et al. “Preoperative vaginal estrogen and midurethral sling exposure: a retrospective cohort study.” Int Urogynecol J 27.3 (2016): 413–7.

8.      Памфамиров, Ю.К. К вопросу об оперативном лечении пролапса гениталий / Ю.К. Памфамиров, Н.М. Романенко, Г.А. Пучкина, А.В. Самойленко // Вестник науки и образования. – 2017. – №2 (26). – С. 92–95.

11.    Al-Zahrani, A.A., Gajewski, J. “Urodynamic findings in women with refractory overactive bladder symptoms.” Int J Urol 23.1 (2016): 75–9.

12.    Caliskan, A., Ozeren, M., Goeschen, K. “Modified posterior intravaginal slingplasty: does the additional bilateral tape attachment to the sacrospinous ligament improve the results?” Cent European J Urol 71.3 (2018): 326–33.

13.    Basu, M., Wise, B., Duckett, J. “Urgency resolution following prolapse surgery: is voiding important?” Int Urogynecol J 24.8 (2013): 1309–13.

14.    Goeschen, K. “Role of uterosacral ligaments in the causation and cure of chronic pelvic pain syndrome.” Pelviperineology 34 (2015): 2–20.

15.    Резниченко, Н.А. Диагностика и лечение патологии шейки матки, ассоциированной с сексуально-трансмиссивными заболеваниями / Н.А. Резниченко , Е.Ф. Белявцева // Здоровье женщины. – 2013. – №10 (86). – С. 39–43.

16. Патент №142834 Україна, МПК А61В 17/00. Cпосіб лікування та профілактика рецидиву генітального пролапсу 3–4 ступеня у жінок похилого віку // Лазуренко В.В., Сафонов Р.А., Лященко О.А., Овчаренко О.Б., Каліновська О.І. – № u2020 00986; заявл. 17.02.2020; опубл. 25.06.2020, бюл. № 12.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)